Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancerCharline Ogier, Christel Larbouret, Corinne Bousquet et al.|Cancer Letters|2018Cited by 57
ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cellsChristophe Le Clorennec, Thierry Chardès|Cell Communication and Signaling|2019Cited by 35
The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activationChristophe Le Clorennec, Thierry Chardès|Oncotarget|2016Cited by 25
Biasing HER4 Tyrosine Kinase Signaling with Antibodies: Induction of Cell Death by Antibody-Dependent HER4 Intracellular Domain TraffickingRomain Lanotte, Thierry Chardès|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 0